
Johnson & Johnson
JNJ · NYSE · Healthcare / Drug Manufacturers - General
Price History
Full chartMarket Stats
About
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CEOMr. Joaquin Duato
- Employees138.20K
- HeadquartersOne Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933, USA
- Websitehttps://www.jnj.com
Leadership
- Mr. Joaquin DuatoCEO & Chairman · b. 1963
- Mr. Joseph James Wolk CPAExecutive VP & CFO · b. 1967
- Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine and R&D · b. 1958
- Mr. Timothy SchmidExecutive VP & Worldwide Chairman of MedTech · b. 1970
- Mr. Robert J. Decker Jr.Controller & Chief Accounting Officer · b. 1973
- Mr. James SwansonExecutive VP & Chief Information Officer · b. 1966
- Mr. Ryan KoorsVice President of Investor Relations
- Mr. Dirk BrinckmanChief Compliance Officer
- Ms. Elizabeth Forminard J.D.Executive VP & Chief Legal Officer · b. 1971
- Ms. Kristen Blair MulhollandExecutive VP & Chief Human Resources Officer · b. 1967
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy11
- Buy5
- Hold6
- Strong Sell1
Ownership Breakdown
- Institutions
- 76.73%
- Insiders
- 0.05%
- Retail / Other
- 23.22%
Top Institutional Holders
- BlackRock Inc212.10M8.80%
- Vanguard Capital Management, LLC157.23M6.52%
- State Street Corp133.78M5.55%
- Vanguard Portfolio Management, LLC64.37M2.67%
- Geode Capital Management, LLC59.09M2.45%
- JPMorgan Chase & Co58.30M2.42%
- Morgan Stanley - Brokerage Accounts44.72M1.86%
- NORGES BANK31.83M1.32%
- State Farm Mutual Automobile Ins Co31.59M1.31%
- Northern Trust Corp28.79M1.19%
- Bank of America Corp23.44M0.97%
- T. Rowe Price Associates, Inc.23.00M0.95%
- FMR Inc22.60M0.94%
- Wellington Management Company LLP22.59M0.94%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest76.50M3.17%
- Vanguard 500 Index Investor63.95M2.65%
- iShares Core S&P 500 ETF32.11M1.33%
- Fidelity 500 Index31.25M1.30%
- State Street® SPDR® S&P 500® ETF29.56M1.23%
- Vanguard MStar Value Index Investor23.01M0.95%
Dividends
Stock Splits
- Jun 13, 20012:1
- Jun 12, 19962:1
- Jun 10, 19922:1
- May 11, 19892:1
- May 19, 19813:1
- May 18, 19703:1